Public-domain · open source
OpenJurist
← 912 F.2d 80 - Spivey v. United States

Spivey v. United States’s Empirical Analysis

912 F.2d 80 · 1990

Citation profile

22
cited by 22 later decisions
1
states following
March 2015
most recently cited

7 federal appellate · 2 district · 1 state decisions

How this case has been cited

Cited by 22 later decisions — most recently March 2015

7 federal appellate · 2 district · 1 state decisions

110199020002010decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Applies 28 U.S.C. § 2675

Relies on Ingraham v. Wright · Stewart v. RCA Corp. · Kielwien v. United States · 239 F. Supp. 152 - Smith v. United States

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 22 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “Tardive dyskinesia is a known possible side effect of the medications which Mrs. Spivey began taking in the fall of 1985. However, prior to August 1987, Mrs. Spivey exhibited no symptoms of that side effect. Therefore, we affirm the court’s finding that the occurrence of this side effect, after the administrative claim was submitted, was “newly discovered” evidence within the meaning of § 2675(b).”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.